Офтальмохирургия. 2022; : 15-19
Брахитерапия в лечении вазопролиферативной опухоли сетчатки
https://doi.org/10.25276/0235-4160-2022-2-15-19Аннотация
Цель. Анализ эффективности брахитерапии Ru106 при лечении вазопролиферативной опухоли (ВПО) – новообразования сетчатки c выраженным сосудистым компонентом.
Материал и методы. Группу наблюдения составили 17 пациентов (17 глаз), редняя острота зрения до лечения – 0,3, средняя высота очага по данным В-сканирова ния – 3,34 мм.
Результаты. После лечения средняя острота зрения составляла 0,2, в большинстве случаев отмечалось уменьшение высоты очага ВПО, в среднем на 1,4 мм.
Заключение. Брахитерапия Ru106 показала свою эффективность в качестве метода лечения ВПО.
Список литературы
1. Shields CL, Shields JA, Barrett J, De Potter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol. 1995;113: 615–623. doi: 10.1001/archopht.1995.01100050083035
2. Medlock RD, Shields JA, Shields CL, Yarian DL, Beyrer CR. Retinal hemangiomalike lesions in eyes with retinitis pigmentosa. Retina. 1990;10(4): 274–277. doi: 10.1097/00006982-199010000-00009
3. Shields CL, Kaliki S, Al-Dahmash S, et al. Retinal vasoproliferative tumors: comparative clinical features of primary versus secondary tumors in 334 cases. JAMA Ophthalmol. 2013;131(3): 328–334. doi: 10.1001/2013.jamaophthalmol.524
4. Chow CC, Blair MP, Shapiro MJ. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011;129(9): 1234–1235. doi: 10.1001/archophthalmol.2011.265
5. Mori K, Ohta K, Murata T. Vasoproliferative tumors of the retina secondary to ocular toxocariasis. Can J Ophthalmol. 2007;42(5): 758–759. doi: 10.3129/i07-137
6. Tranos P, Clare G, Sullivan P. Vasoproliferative tumor of the retina after spontaneous reattachment of rhegmatogenous retinal detachment. Retina. 2006;26(4): 475–476. doi: 10.1097/01.iae.0000238541.21262.4b
7. Gottlieb F, Fammartino JJ, Stratford TP, Brockhurst RJ. Retinal angiomatous mass: a complication of retinal detachment surgery. Retina. 1984;4: 152–157. doi: 10.1097/00006982-198400430-00004
8. Gray RH, Gregor ZJ. Acquired peripheral retinal telangiectasia after retinal surgery. Retina. 1994;14: 10–13. doi: 10.1097/00006982-199401000-00003
9. Rennie IG. Retinal vasoproliferative tumours. Eye. 2010;24: 468–471. doi: 10.1038/eye.2009.305
10. Krivosic V, Massin P, Desjardins L, Le Hoang P, Tadayoni R, Gaudric A. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation. Am J Ophthalmol. 2014;158(1): 154–161. doi: 10.1016/j.ajo.2014.03.005
11. Hussain RN, Jmor F, Damato B, et al. Verteporfin photodynamic therapy for the treatment of retinal vasoproliferative tumors. Ophthalmology. 2015;122: 2361–2363. doi: 10.1097/01.iae.0000238554.61165.fd
12. Saldanha MJ, Edrich C. Treatment of vasoproliferative tumors with photodynamic therapy. Ophthalmic Surg Lasers Imaging. 2008;39: 143–145. doi: 10.3928/15428877-20080301-13
13. Сдобникова С.В., Сургуч В.К., Большунов А.В., Сосновский В.В., Троицкая Н.А. Комбинированная транссклеральная и транспупиллярная термотерапия при больших вазопролиферативных опухолях сетчатки. Вестник офтальмологии. 2014;1: 85–90.
14. Marback EF, Guerra RL, de Oliveira Maia OJr, et al. Retinal vasoproliferative tumor. Arq Bras Oftalmol. 2013;76: 200–203. doi: 10.1590/s0004-27492013000300016
15. Yeh S, Wilson DJ. Pars plana vitrectomy and endoresection of a retinal vasoproliferative tumor. Arch Ophthalmol. 2010;128(9): 1196–1199. doi: 10.1001/archophthalmol.2010.194
16. Городецкая Ю.Б., Яровой А.А., Горшков И.М., Логинов Р.А. Вазопролиферативные опухоли сетчатки. Современный подход к лечению. Офтальмохирургия. 2021;(2): 86–93. doi: 10.25276/0235-4160-2021-2-86-93.
17. Rogers C, Damato B, Kumar I, Heimann H. Intravitreal bevacizumab in the treatment of vasoproliferative retinal tumours. Eye. 2014;28: 968–973. doi: 10.1038/eye.2014.113
18. Юнина М.А., Педанова Е.К., Крыль Л.А. Первые результаты фокальной лазеркоагуляции реактивной ретинальной астроцитарной опухоли. Современные технологии в офтальмологии. 2015;3: 194–195. Smith J, Steel D. The surgical management of vasoproliferative tumours. Ophthalmologica. 2011;226(Suppl 1): 42–45. doi: 10.1159/000328209
19. Anastassiou G, Bornfeld N, Schueler AO, et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol. 2006;90(4): 447–450. doi: 10.1136/bjo.2005.081422
20. Rodrigues LD, Serracarbassa LL, Rosa H, Nakashima Y, Serracarbassa PD. Tumor vasoproliferativo associado a tuberculose ocular presumida: relato de caso. Arq Bras Oftalmol. 2007;70(3): 527–531. [Rodrigues LD, Serracarbassa LL, Rosa H, Nakashima Y, Serracarbassa PD. Vasoproliferative tumor associated with presumed ocular tuberculosis: case report. Arq Bras Oftalmol. 2007;70(3): 527–531. (In Portug.)] doi: 10.1590/s0004-27492007000300025
21. Cohen VM, Shields CL, Demirci H, Shields JA. Iodine I125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. Arch Ophthalmol. 2008;126(9): 1245–1251. doi: 10.1001/archopht.126.9.1245
22. Shields JA, Decker WL, Sanborn GE, et al. Presumed acquired retinal hemangiomas. Ophthalmology. 1983;90: 1292–1300. doi: 10.1016/s0161-6420(83)34389-x
23. Heimann H, Bornfeld N, Vij O, et al. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000;84(10): 116–1169. doi: 10.1136/bjo.84.10.1162
24. Garcia-Arumi J, Diestefano LN, Fonollosa A, Quijano C, Corcostegui B. Management of vision-threatening complications of vasoproliferative tumors of the retina. Ophthalmic Res. 2015;54(1): 34–40. doi: 10.1159/000430955
25. Brockmann C, Rehak M, Heufelder J, et al. Predictors of treatment response of vasoproliferative retinal tumors to ruthenium-106 brachytherapy. Retina. 2016; 36(12): 2384–2390.
26. Abolfathzadeh N, Naseripour M, Jaberi R, et al. Ru-106 plaque radiotherapy for vasoproliferative tumors of retina: a 15-year single-center experience. Int Ophthalmol. 2020. 40(8): 2095–2102. doi: 10.1007/s10792-020-01386-5
Fyodorov Journal of Ophthalmic Surgery. 2022; : 15-19
Brachytherapy as a treatment of a vasoproliferative retinal tumor
https://doi.org/10.25276/0235-4160-2022-2-15-19Abstract
Purpose. To analyze the effectiveness of Ru106 brachytherapy in the treatment of the vasoproliferative tumor (VPT) – a neoplasm of the retina with a pronounced vascular component.
Material and methods. The observation group consisted of 17 patients (17 eyes), the average lesion height according to B-scan data was 3.34 mm.
Results. After treatment the average visual acuity was 0.2, in most cases there was a decrease in the height of the VPT focus, on average by 1.4 mm.
Conclusion. Brachytherapy Ru106 has shown its effectiveness as a method of treating VPT.
References
1. Shields CL, Shields JA, Barrett J, De Potter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol. 1995;113: 615–623. doi: 10.1001/archopht.1995.01100050083035
2. Medlock RD, Shields JA, Shields CL, Yarian DL, Beyrer CR. Retinal hemangiomalike lesions in eyes with retinitis pigmentosa. Retina. 1990;10(4): 274–277. doi: 10.1097/00006982-199010000-00009
3. Shields CL, Kaliki S, Al-Dahmash S, et al. Retinal vasoproliferative tumors: comparative clinical features of primary versus secondary tumors in 334 cases. JAMA Ophthalmol. 2013;131(3): 328–334. doi: 10.1001/2013.jamaophthalmol.524
4. Chow CC, Blair MP, Shapiro MJ. Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011;129(9): 1234–1235. doi: 10.1001/archophthalmol.2011.265
5. Mori K, Ohta K, Murata T. Vasoproliferative tumors of the retina secondary to ocular toxocariasis. Can J Ophthalmol. 2007;42(5): 758–759. doi: 10.3129/i07-137
6. Tranos P, Clare G, Sullivan P. Vasoproliferative tumor of the retina after spontaneous reattachment of rhegmatogenous retinal detachment. Retina. 2006;26(4): 475–476. doi: 10.1097/01.iae.0000238541.21262.4b
7. Gottlieb F, Fammartino JJ, Stratford TP, Brockhurst RJ. Retinal angiomatous mass: a complication of retinal detachment surgery. Retina. 1984;4: 152–157. doi: 10.1097/00006982-198400430-00004
8. Gray RH, Gregor ZJ. Acquired peripheral retinal telangiectasia after retinal surgery. Retina. 1994;14: 10–13. doi: 10.1097/00006982-199401000-00003
9. Rennie IG. Retinal vasoproliferative tumours. Eye. 2010;24: 468–471. doi: 10.1038/eye.2009.305
10. Krivosic V, Massin P, Desjardins L, Le Hoang P, Tadayoni R, Gaudric A. Management of idiopathic retinal vasoproliferative tumors by slit-lamp laser or endolaser photocoagulation. Am J Ophthalmol. 2014;158(1): 154–161. doi: 10.1016/j.ajo.2014.03.005
11. Hussain RN, Jmor F, Damato B, et al. Verteporfin photodynamic therapy for the treatment of retinal vasoproliferative tumors. Ophthalmology. 2015;122: 2361–2363. doi: 10.1097/01.iae.0000238554.61165.fd
12. Saldanha MJ, Edrich C. Treatment of vasoproliferative tumors with photodynamic therapy. Ophthalmic Surg Lasers Imaging. 2008;39: 143–145. doi: 10.3928/15428877-20080301-13
13. Sdobnikova S.V., Surguch V.K., Bol'shunov A.V., Sosnovskii V.V., Troitskaya N.A. Kombinirovannaya transskleral'naya i transpupillyarnaya termoterapiya pri bol'shikh vazoproliferativnykh opukholyakh setchatki. Vestnik oftal'mologii. 2014;1: 85–90.
14. Marback EF, Guerra RL, de Oliveira Maia OJr, et al. Retinal vasoproliferative tumor. Arq Bras Oftalmol. 2013;76: 200–203. doi: 10.1590/s0004-27492013000300016
15. Yeh S, Wilson DJ. Pars plana vitrectomy and endoresection of a retinal vasoproliferative tumor. Arch Ophthalmol. 2010;128(9): 1196–1199. doi: 10.1001/archophthalmol.2010.194
16. Gorodetskaya Yu.B., Yarovoi A.A., Gorshkov I.M., Loginov R.A. Vazoproliferativnye opukholi setchatki. Sovremennyi podkhod k lecheniyu. Oftal'mokhirurgiya. 2021;(2): 86–93. doi: 10.25276/0235-4160-2021-2-86-93.
17. Rogers C, Damato B, Kumar I, Heimann H. Intravitreal bevacizumab in the treatment of vasoproliferative retinal tumours. Eye. 2014;28: 968–973. doi: 10.1038/eye.2014.113
18. Yunina M.A., Pedanova E.K., Kryl' L.A. Pervye rezul'taty fokal'noi lazerkoagulyatsii reaktivnoi retinal'noi astrotsitarnoi opukholi. Sovremennye tekhnologii v oftal'mologii. 2015;3: 194–195. Smith J, Steel D. The surgical management of vasoproliferative tumours. Ophthalmologica. 2011;226(Suppl 1): 42–45. doi: 10.1159/000328209
19. Anastassiou G, Bornfeld N, Schueler AO, et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br J Ophthalmol. 2006;90(4): 447–450. doi: 10.1136/bjo.2005.081422
20. Rodrigues LD, Serracarbassa LL, Rosa H, Nakashima Y, Serracarbassa PD. Tumor vasoproliferativo associado a tuberculose ocular presumida: relato de caso. Arq Bras Oftalmol. 2007;70(3): 527–531. [Rodrigues LD, Serracarbassa LL, Rosa H, Nakashima Y, Serracarbassa PD. Vasoproliferative tumor associated with presumed ocular tuberculosis: case report. Arq Bras Oftalmol. 2007;70(3): 527–531. (In Portug.)] doi: 10.1590/s0004-27492007000300025
21. Cohen VM, Shields CL, Demirci H, Shields JA. Iodine I125 plaque radiotherapy for vasoproliferative tumors of the retina in 30 eyes. Arch Ophthalmol. 2008;126(9): 1245–1251. doi: 10.1001/archopht.126.9.1245
22. Shields JA, Decker WL, Sanborn GE, et al. Presumed acquired retinal hemangiomas. Ophthalmology. 1983;90: 1292–1300. doi: 10.1016/s0161-6420(83)34389-x
23. Heimann H, Bornfeld N, Vij O, et al. Vasoproliferative tumours of the retina. Br J Ophthalmol. 2000;84(10): 116–1169. doi: 10.1136/bjo.84.10.1162
24. Garcia-Arumi J, Diestefano LN, Fonollosa A, Quijano C, Corcostegui B. Management of vision-threatening complications of vasoproliferative tumors of the retina. Ophthalmic Res. 2015;54(1): 34–40. doi: 10.1159/000430955
25. Brockmann C, Rehak M, Heufelder J, et al. Predictors of treatment response of vasoproliferative retinal tumors to ruthenium-106 brachytherapy. Retina. 2016; 36(12): 2384–2390.
26. Abolfathzadeh N, Naseripour M, Jaberi R, et al. Ru-106 plaque radiotherapy for vasoproliferative tumors of retina: a 15-year single-center experience. Int Ophthalmol. 2020. 40(8): 2095–2102. doi: 10.1007/s10792-020-01386-5
